News and Breakthroughs

Patients with advanced-stage melanoma who received immunotherapy both before and after surgery had longer event-free survival than patients who received immunotherapy only after surgery, according to a recent clinical trial published in the New England Journal of Medicine.

Northwestern Medicine scientists have identified a new compound which could inform future HIV cure strategies, according to research published in Science Advances.

Northwestern Medicine scientists have developed a new tool to predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas.

During these extraordinary times, we need exceptional people to blaze new trails -- pushing the boundaries of scientific discovery, moving innovations into the clinical setting, sharing vital cancer education and services in the larger community, and providing the highest level of compassionate care to our patients and families across Northwestern Medicine.

Get to know Lurie Cancer Center member, Kehinde Adekola, MD, MS. Dr. Adekola, associate professor in the Division of Hematology and Oncolog and co-chair of the Diversity and Cultural Affairs Council (DCAC) of the Department of Medicine at Northwestern University Feinberg School of Medicine, was featured in the latest issue of Northwestern Medicine’s “Diversity, Equity & Inclusion Quarterly.”

Northwestern Medicine scientists have identified a gene that plays a role in cellular responses to molecular stressors, such as DNA damage and nutrient scarcity.

Investigators have discovered that a specific complex drives cell proliferation in mutated myeloproliferative neoplasms, suggesting this complex could serve as an ideal therapeutic target, according to a recent Northwestern medicine study.

A new way to significantly increase the potency of almost any vaccine has been developed by Northwestern scientists.

Scientists have identified a new cell type implicated in the development of medulloblastoma, according to a study published in Nature.

The National Comprehensive Cancer Network’s new Diversity, Equity, & Inclusion (DEI) Directors Forum is working to improve diversity of clinical staff representation across the nation’s leading academic cancer centers. June McKoy, MD, MPH, JD, MBA, assistant director of Diversity, Equity, and Inclusion at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, has been selected to join the forum.

We are pleased to announce that Sofia Garcia, PhD, has been named director of the Cancer Survivorship Institute of the Lurie Cancer Center, effective January 1, 2023.

Patients with relapsed or refractory hairy cell leukemia who were treated with vemurafenib experienced excellent response and relapse-free survival, according to a recent clinical trial published in Blood.

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University is pleased to announce that Mario Shields, PhD, a research assistant professor of Medicine in the Division of Hematology and Oncology, has received the first Diversity Scholars Award.

Patient-reported outcomes in relapsed or refractory large B-cell lymphoma revealed that receiving CAR T-cell immunotherapy was associated with higher quality of life, according to a recent study.

Investigators have developed a novel personalized T-cell therapy approach that may identify specific targets unique to a patient’s cancer cells more effectively than current treatments, according to findings published in Nature.